HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antitumor effect of combination of S-1 and docetaxel on the human breast cancer xenograft transplanted into SCID mice.

Abstract
In vivo experiments were performed on breast cancer xenografts to examine whether the combination therapy with S-1, an oral dihydrouracil dehydrogenase (DPD) inhibitory fluoropyrimidine, plus docetaxel functions as an additive/synergistic modulator in tumor growth. The human breast cancer xenograft, MDA-MB-435SHM, was inoculated into SCID female mice. The tumor growth and thymidylate synthase (TS)/DPD activity of tumors treated with the agents were investigated. The T/C value (relative mean tumor weight of the treated group/relative tumor weight of the control group) of the group treated with docetaxel, S-1 and combination therapy were 45.3, 63.1 and 29.8%, respectively; suggesting the positive antitumor effects of the combination therapy in particular. In addition, significant down-regulation of DPD activity was also observed in the tumors treated with S-1, docetaxel and their combination. Down-regulation of the DPD activity of the tumors is also considered to be correlated with the antitumor effect of the treated groups, suggesting its influence on the synergistic effect of the combination therapy.
AuthorsAkihiko Suto, Tetsuro Kubota, Masakazu Fukushima, Tadashi Ikeda, Toshio Takeshita, Harumi Ohmiya, Masaki Kitajima
JournalOncology reports (Oncol Rep) Vol. 15 Issue 6 Pg. 1517-22 (Jun 2006) ISSN: 1021-335X [Print] Greece
PMID16685389 (Publication Type: Journal Article)
Chemical References
  • Drug Combinations
  • Taxoids
  • S 1 (combination)
  • Tegafur
  • Docetaxel
  • Oxonic Acid
  • Dihydrouracil Dehydrogenase (NAD+)
  • Thymidylate Synthase
Topics
  • Animals
  • Antineoplastic Combined Chemotherapy Protocols (pharmacology)
  • Breast Neoplasms (drug therapy, enzymology)
  • Dihydrouracil Dehydrogenase (NAD+) (antagonists & inhibitors, metabolism)
  • Docetaxel
  • Drug Combinations
  • Drug Synergism
  • Female
  • Humans
  • Mice
  • Mice, SCID
  • Oxonic Acid (administration & dosage)
  • Taxoids (administration & dosage)
  • Tegafur (administration & dosage)
  • Thymidylate Synthase (metabolism)
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: